Sequenom Announces Appointment Of Bill Bowen To Senior Vice President And General Counsel
October 11, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Bill Bowen as Senior Vice President and General Counsel. Mr. Bowen will report to Dr. Harry F. Hixson, Chairman and CEO and will be responsible for all company legal and patent activities. "With Mr. [...]
New Malaria Monoclonal Antibodies
October 11, 2012
Malaria is a mosquito-borne parasitic infection caused by several species of Plasmodium. It is prevalent world wide in subtropical regions of Africa, Asia and the Americas. Symptoms include fever and headache but can proceed to coma and death. The majority of deaths are caused by P. falciparum. During the blood stage infection, P. falciparum secretes [...]
New Website Delivers Phenomenex Web Tools Round-the-Clock in Chinese
October 11, 2012
Torrance, CA - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the launch of a new Chinese website. The site delivers all Phenomenex web-based tools, including the company's unique structure search capability, to the growing China market where Internet use is very high. Chinese users [...]
Scientifica Presented with Queen’s Award for Enterprise
October 11, 2012
The presentation was also attended by local MP, Charles Hendry, along with Scientifica’s team from its Uckfield and Maidenhead offices and specially invited guests. These included Councillors Chris Dowling, Jonica Fox and John Carvey, Mayor of Uckfield, and David Marshall, Chairman of The Uckfield Chamber of Commerce. The Queen’s Award for Enterprise recognises the contribution [...]
October 10, 2012
Walkersville, MD (USA),– The National Institutes of Health Center for Regenerative Medicine (NIH CRM) has awarded Lonza Walkersville, Inc. a contract to generate induced pluripotent stem cells (iPSCs) under current Good Manufacturing Practices (cGMP). The production of clinical grade iPSCs is considered a critical component to realizing the therapeutic potential of pluripotent stem cells. The [...]
October 10, 2012
Ithaca, NY – Advion, Inc., a leading life sciences Systems and Consumables developer, announces the appointment of Vijay Gupta, PhD as Vice President International Business Development and Support focused on the expression compact mass spectrometer (CMS). This continues Advion’s expansion within all areas of the organization from manufacturing, service/support and sales and marketing, which has [...]
Corning Announces Expanded Portfolio of Serum-free Cell Culture Media
October 10, 2012
CORNING, N.Y., -- Corning Incorporated (NYSE: GLW) today announced the expansion of Mediatech, Inc.’s serum-free product portfolio with the addition of two new cell culture media. The Corning® Hepatocyte Maintenance Medium and the Corning stemgro® MSC Medium capitalize on the growing global demand for specifically defined, serum-free media. The media can enable lab researchers to [...]
October 10, 2012
Powder characterisation company Freeman Technology (Tewkesbury, UK) has announced significant expansion into Asia with the appointment of Dr Nishil Malde as General Manager for Asia Pacific and the extension of its distribution agreement with Asia specialists DKSH, to now include China. Managing Director Tim Freeman said: “Our business in Asia continues to grow and moving [...]
Secondary Antibodies Provider Jackson ImmunoResearch Expands Laboratory Facilities
October 10, 2012
Leading secondary antibodies supplier, Jackson ImmunoResearch, has expanded its facilities in response to increasing demand for its products worldwide. Offices at West Grove, Philadelphia, have seen the following:- Construction of a 13,000 square feet addition bringing the total site to 40,000 square feet Existing production laboratories doubled in size Quality Assurance and Product Development laboratories [...]
October 9, 2012
Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today announced the availability of a comprehensive portfolio of products and technologies for enhancing drug bioavailability. Supported by a legacy of expertise in pharmaceutical raw materials and technologies, the portfolio addresses major challenges in pharmaceutical formulation. This includes products for all [...]
